Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.09) by 255.56 percent. This is a 117.49 percent decrease over earnings of $1.83 per share from the same period last year.